# Immunophenotypic Evaluation of IL-7R α in Acute Leukaemia

> **NCT05643547** · — · UNKNOWN · sponsor: **Rania Abdeltwab Abdelazeim** · enrollment: 83 (estimated)

## Conditions studied

- Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05643547
- **Lead sponsor:** Rania Abdeltwab Abdelazeim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05643547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05643547, "Immunophenotypic Evaluation of IL-7R α in Acute Leukaemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05643547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*